Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/04/2003WO2003053216A3 Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003050267A3 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
12/04/2003WO2003050266A3 Tissue engineered cellular sheets, methods of making and use thereof
12/04/2003WO2003048329A3 Chromosomal saturation mutagenesis
12/04/2003WO2003046141A3 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003040298B1 Cell and tissue growth using substances that reversibly bind oxygen
12/04/2003WO2003032920A3 Oligonucleotide modulation of cell adhesion
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003029417A3 Nutrient medium for maintaining neural cells in injured nervous system
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003026404A3 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003026398A3 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003024406A3 Nestin-expressing hair follicle stem cells
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003014328A3 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
12/04/2003WO2003012058A3 Media and methods for cultivation of microorganisms
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003007987A3 Haptenizing cancer cell components for the preparation of cancer vaccines
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003006504A3 Allelic variants of gpr50
12/04/2003WO2003001876A3 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002099068A3 LCES AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/04/2003WO2002091926A3 Inhibitors of dna methyltransferase isoforms
12/04/2003WO2002087499A3 Cells for detection of enteroviruses
12/04/2003WO2002086144A3 Compositions and methods for recombinational cloning of nucleic acid molecules
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002083892A3 Mutants of desoxycytidine kinase having extended enzymatic activity
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002081626A3 D-hydantoinase from ochrobactrum anthropi
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002079382A3 B-ephrin regulation of g-protein coupled chemoattraction; compositions and methods of use
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002070555A3 Method of modulating the proliferation of medullary thyroid carcinoma cells
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002064742A3 Compounds effecting neuron remodeling and assays for same
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030226177 Dwarfism genes and dwarf plants
12/04/2003US20030226172 Preparing and recovering transgenic and disease resistant grapevines; biological pest control; immunoassay
12/04/2003US20030226171 Insect resistant plants and methods for making same
12/04/2003US20030226165 Methods for producing cotyledonary pine embryos utilizing a gibberellin
12/04/2003US20030226164 Using recombinase to obtain site-specific recombination of DNA within dicotyledonous and monocotyledonous plant cells
12/04/2003US20030226163 Preparing trangenic cells which comprise 3-hydroxy-3-methylglutaryl CoA reductase regulatory sequences for use in expression of heterologous polypeptides; biological pest control; bioreactors
12/04/2003US20030226162 Genetically engineered woody plants with enhanced glucosyltransferase activity; papermaking
12/04/2003US20030226161 Salutaridinol 7-O-acetyltransferase and derivatives thereof
12/04/2003US20030226159 Preparation of transgenic animal model for monitoring tumor development and treatments using stem cells
12/04/2003US20030226154 Pathophysiology associated with a single gene (MASS 1) mutation underlying the robust audiogenic seizure phenotype in frings mice
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225117 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030225010 Novel compositions and methods for the regulation of proliferation of stem cells
12/04/2003US20030225006 Novel spinosyn-producing polyketide synthases
12/04/2003US20030224995 Treatment of burns
12/04/2003US20030224983 Stimulation of beta cell proliferation
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224520 Activation and expansion of T-cells using an engineered multivalent signaling platform
12/04/2003US20030224518 Cartilage composites and methods of use
12/04/2003US20030224517 Comprises oligonucleotides which inhibit secretase activity on amyloid precursor proteins (APP) for treating alzheimer's and neurodegenerative diseases
12/04/2003US20030224510 Inducing cell differentiation in trangenic cells; regenerative medcine; transplantation therapy
12/04/2003US20030224501 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
12/04/2003US20030224500 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
12/04/2003US20030224495 Synthesis performed in enantiomer-pure form with chorismate by cultivation of genetically altered non-pathogenic organism which has aromate embolism and increased activity of isochorismate synthase and isochorismatase
12/04/2003US20030224490 Fusion partner cells and uses thereof
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224477 Comprises nucleotide sequences associated with expression vectors for improving gene transfer and expression in cells
12/04/2003US20030224466 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224420 Using differential labeling of progenitor tissue separate cell of different cell lineage and to detect carcinogenesis, cell proliferative, autoimmune and diabetic; nuclear magnetic resonance; antiproliferative agents; mass spectrometry
12/04/2003US20030224411 Genes that are up- or down-regulated during differentiation of human embryonic stem cells
12/04/2003US20030224405 Transcriptional regulator
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224398 Purification of the leading front of migratory cells
12/04/2003US20030224388 RIP2: a mediator of signaling in the innate and adaptive immune systems
12/04/2003US20030224381 Delta-erythroid kruppel-like factors and methods of use
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224350 Elimination of endogenous porcine retrovirus
12/04/2003US20030224345 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223974 Highly purified hepatic stem cells are trans-differentiated into pancreatic endocrine hormone-producing cells by culturing them in vitro in a medium containing high levels of glucose. These trans differentiated cells express insulin, glucagon and
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1827